参考文献/References:
[1]CSCO神经内分泌肿瘤专家委员会.中国胃肠胰神经内分泌肿瘤专家共识.临床肿瘤学杂志, 2013,18(9):815-832.
[2]Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO classification of tumours of the digestive system. Lyon: IARC Press,2010.26-27.
[3]Fraenkel M, Kim M, Faggiano A, et al. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer, 2013, 21(3):R153-R163.
[4]唐承薇,郭林杰.我国胃肠胰神经内分泌肿瘤临床现状分析.中国实用外科杂志, 2014,34(6):490-492.
[5]Niederle MB, Hackl M, Kaserer K, et al. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer, 2010, 17(4):909-918.
[6]余英豪, 胡舜.胃肠胰神经内分泌肿瘤临床病理的十个重要问题.临床与实验病理学杂志,2015,31(10):1081-1084.
[7]Caplin M, Sundin A, Nillson O, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology,2012,95(2):88-97.
[8]Ishii N, Horiki N, Itoh T, et al. Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors. Surg Endosc, 2010, 24(6):1413-1419.
[9]周鑫, 傅卫.直肠神经内分泌肿瘤的微创治疗.中国微创外科杂志,2014,14(1):74-76.
[10]Zhong DD, Shao LM, Cai JT. Endoscopic mucosal resection vs. endoscopic submucosal dissection for rectal carcinoid tumours: a systematic review and meta-analysis. Colorectal Dis,2013,15(3):283-291.
[11]Suzuki S, Ishii N, Uemura M, et al. Endoscopic submucosal dissection (ESD) for gastrointestinal carcinoid tumors. Surg Endosc,2012,26(3):759-763.